The Quality of Anti-SARS-CoV-2 T Cell Responses Predicts the Neutralizing Antibody Titer in Convalescent Plasma Donors

Convalescent plasma therapy has been described as an attractive approach to treat critically ill patients with COVID-19 (Coronavirus disease 2019). The selection of convalescent plasma donors (CPD) is commonly based on neutralizing antibody titer. A better understanding of the quality of immune resp...

Descripción completa

Detalles Bibliográficos
Autores principales: Kroemer, Marie, Boullerot, Laura, Ramseyer, Mélanie, Spehner, Laurie, Barisien, Christophe, Gravelin, Eleonore, Renaudin, Adeline, Cognasse, Fabrice, Gallian, Pierre, Hermine, Olivier, Lacombe, Karine, Tiberghien, Pierre, Adotévi, Olivier
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Public Health
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8965758/
https://www.ncbi.nlm.nih.gov/pubmed/35372242
http://dx.doi.org/10.3389/fpubh.2022.816848

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8965758/
https://www.ncbi.nlm.nih.gov/pubmed/35372242
http://dx.doi.org/10.3389/fpubh.2022.816848

Ejemplares similares